AbbVie Inc.
ABBV 256.46 (-1.39%) 3.56
EV: $528.15(B)
Total Equity: $-5.89(B)
Debt/Equity: 48
Dividend/share: $6.8
Div. yield: 2.66%
P/E: 72.45
Forward P/E: 18.31
P/FCF: 24.87
P/S: 7.05
P/B: N/A
EPS: $3.5
EPS (fwd): $14.0
FCF/share: $10.3
Revenue/share: $36.4
Book value/share: $-3.4
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Margins: Gross | Op. | Net
72.8% | 24.1% | 9.8%
0.0%of Portfolio
My holdings
Day change
Total change
Growth Estimates
Revenue
CAGR5.9%TTM
$64.39(B)
FY+1
22
5%
$67.58(B)
FY+2
21
9%
$73.52(B)
FY+3
18
8%
$79.06(B)
FY+4
12
6%
$83.77(B)
FY+5
12
3%
$85.92(B)
Net Income
CAGR41.6%TTM
$6.31(B)
FY+1
20
293%
$24.83(B)
FY+2
19
16%
$28.77(B)
FY+3
17
11%
$31.99(B)
FY+4
11
8%
$34.66(B)
FY+5
11
4%
$35.96(B)
EPS
CAGR42.1%TTM
$3.54
FY+1
25
296%
$14.01
FY+2
24
16%
$16.28
FY+3
18
11%
$18.01
FY+4
12
9%
$19.72
FY+5
12
4%
$20.52
FCF per share
CAGR15.5%TTM
$10.31
FY+1
4
32%
$13.60
FY+2
3
64%
$22.36
FY+3
3
7%
$20.80
FY+4
2
1%
$21.10
FY+5
2
0%
$21.15